Seegene Rises 7.23% Amid COVID-19 (Diagnostic Kit) Theme Uptrend

On the 27th, the COVID-19 (diagnostic kit) theme rose by 3.17% compared to the previous day, showing strength, while Seegene, a related stock drawing attention, surged by 7.23% compared to the previous day. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.

[Graph] Major stock price changes in the COVID-19 (diagnostic kit) theme

According to provisional data compiled at 12:26, foreigners are making large net purchases of Seegene, buying 17,000 shares.

[Table] Net purchases by foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Seegene ranks 5th out of 33 stocks in quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as Seegene having relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.